Trial Outcomes & Findings for Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS) (NCT NCT04171050)

NCT ID: NCT04171050

Last Updated: 2025-06-03

Results Overview

Measured in morphine milligram equivalents (MME) at 24 hours

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

44 participants

Primary outcome timeframe

24 hours after surgery

Results posted on

2025-06-03

Participant Flow

Participant milestones

Participant milestones
Measure
Group 1: Local Anesthesia
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Overall Study
STARTED
22
22
Overall Study
COMPLETED
21
21
Overall Study
NOT COMPLETED
1
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Group 1: Local Anesthesia
n=22 Participants
This group was assigned usual care, which involved local anesthesia administered per surgeon preference
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Total
n=44 Participants
Total of all reporting groups
Age, Continuous
63 years
n=5 Participants
66 years
n=7 Participants
65 years
n=5 Participants
Sex: Female, Male
Female
22 Participants
n=5 Participants
22 Participants
n=7 Participants
44 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
White
18 Participants
n=5 Participants
16 Participants
n=7 Participants
34 Participants
n=5 Participants
Race/Ethnicity, Customized
Black
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race/Ethnicity, Customized
Asian
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Race/Ethnicity, Customized
Other
1 Participants
n=5 Participants
2 Participants
n=7 Participants
3 Participants
n=5 Participants
Race/Ethnicity, Customized
Refused to answer
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Region of Enrollment
United States
22 participants
n=5 Participants
22 participants
n=7 Participants
44 participants
n=5 Participants

PRIMARY outcome

Timeframe: 24 hours after surgery

Measured in morphine milligram equivalents (MME) at 24 hours

Outcome measures

Outcome measures
Measure
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Narcotic Use
8 MME
Interval 0.0 to 20.0
6.75 MME
Interval 0.0 to 15.0

PRIMARY outcome

Timeframe: 48 hours after surgery

Measured in MME at 48 hours

Outcome measures

Outcome measures
Measure
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Narcotic Use
8 MME
Interval 0.0 to 26.0
7 MME
Interval 0.0 to 35.0

SECONDARY outcome

Timeframe: 0-2 hours, 2-4 hours, 4-8 hours, 8-12 hours, 24 hours, and 48 hours after surgery

Population: Patients were not present for 8-12 hour assessment (outpatient surgery so they were sent home)

Average pain score by Numerical Rating Scale (NRS). The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).

Outcome measures

Outcome measures
Measure
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Pain Scores
0-2 hours
1.2 score on a scale
Standard Deviation 1.8
1.6 score on a scale
Standard Deviation 2.4
Pain Scores
48 hours
3 score on a scale
Standard Deviation 2
4 score on a scale
Standard Deviation 3
Pain Scores
2-4 hours
1.4 score on a scale
Standard Deviation 1.7
1.1 score on a scale
Standard Deviation 1.8
Pain Scores
4-8 hours
1.9 score on a scale
Standard Deviation 1.8
1.4 score on a scale
Standard Deviation 2.0
Pain Scores
24 hours
4 score on a scale
Standard Deviation 2
3 score on a scale
Standard Deviation 3

SECONDARY outcome

Timeframe: 6 weeks after surgery

Days to return to normal activity, defined as walking, sitting, and performing daily household tasks comfortably. Upon discharge, all participants received a diary to record the date they returned to normal daily activities. Participants were contacted at 2 and 6 weeks postoperatively either by telephone or during their scheduled office visit and were asked about their time to return to normal activity.

Outcome measures

Outcome measures
Measure
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Return to Normal Daily Activities
10 Days
Interval 6.0 to 18.0
10 Days
Interval 7.0 to 11.0

SECONDARY outcome

Timeframe: 48 hours after surgery, 2 weeks after surgery

Population: Participants who completed the study, per Participant Flow.

Satisfaction with postoperative pain control was assessed using a verbal scale of 1=very satisfied, 2=Somewhat satisfied, 3=Neither satisfied nor dissatisfied, 4=Somewhat dissatisfied, 5=very dissatisfied

Outcome measures

Outcome measures
Measure
Group 1: Local Anesthesia
n=21 Participants
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=21 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Patient Satisfaction With Postoperative Recovery
5 - at 2 weeks
2 Participants
1 Participants
Patient Satisfaction With Postoperative Recovery
Not obtained at 2 weeks
2 Participants
0 Participants
Patient Satisfaction With Postoperative Recovery
1 - at 48 hours
16 Participants
13 Participants
Patient Satisfaction With Postoperative Recovery
1 - at 2 weeks
15 Participants
17 Participants
Patient Satisfaction With Postoperative Recovery
2 - at 2 weeks
0 Participants
2 Participants
Patient Satisfaction With Postoperative Recovery
3 - at 2 weeks
2 Participants
0 Participants
Patient Satisfaction With Postoperative Recovery
4 - at 2 weeks
0 Participants
1 Participants
Patient Satisfaction With Postoperative Recovery
2 - at 48 hours
3 Participants
4 Participants
Patient Satisfaction With Postoperative Recovery
3 - at 48 hours
0 Participants
1 Participants
Patient Satisfaction With Postoperative Recovery
4 - at 48 hours
0 Participants
2 Participants
Patient Satisfaction With Postoperative Recovery
5 - at 48 hours
1 Participants
0 Participants
Patient Satisfaction With Postoperative Recovery
Not obtained at 48 hours
1 Participants
1 Participants

SECONDARY outcome

Timeframe: Tracked by hour through time of patient discharge (up to 72 hours)

Tracked in hours

Outcome measures

Outcome measures
Measure
Group 1: Local Anesthesia
n=22 Participants
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 Participants
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Length of Hospital Stay
16.5 Hours
Interval 4.5 to 24.0
9 Hours
Interval 5.0 to 23.0

Adverse Events

Group 1: Local Anesthesia

Serious events: 0 serious events
Other events: 6 other events
Deaths: 0 deaths

Group 2: Local Anesthesia Plus Pudendal Nerve Block

Serious events: 1 serious events
Other events: 7 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Group 1: Local Anesthesia
n=22 participants at risk
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 participants at risk
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
General disorders
hospital readmission
0.00%
0/22 • 6 weeks postoperatively
4.5%
1/22 • Number of events 1 • 6 weeks postoperatively

Other adverse events

Other adverse events
Measure
Group 1: Local Anesthesia
n=22 participants at risk
Standard of care with local anesthesia used during surgery Local anaesthetic: Local anesthesia injections
Group 2: Local Anesthesia Plus Pudendal Nerve Block
n=22 participants at risk
Pudendal Nerve Block (PNB) in addition to local anesthesia used during surgery Pudendal Nerve Block plus anesthesia: Local anesthesia injections plus a pudendal nerve block
Surgical and medical procedures
Pudendal nerve entrapment
0.00%
0/22 • 6 weeks postoperatively
4.5%
1/22 • Number of events 1 • 6 weeks postoperatively
General disorders
Postoperative nausea
4.5%
1/22 • Number of events 1 • 6 weeks postoperatively
0.00%
0/22 • 6 weeks postoperatively
Injury, poisoning and procedural complications
Anesthetic complication
4.5%
1/22 • Number of events 1 • 6 weeks postoperatively
0.00%
0/22 • 6 weeks postoperatively
Renal and urinary disorders
Urinary retention at 48hr
18.2%
4/22 • Number of events 4 • 6 weeks postoperatively
27.3%
6/22 • Number of events 6 • 6 weeks postoperatively

Additional Information

Tamara Grisales, MD

University of California, Los Angeles

Phone: 310-983-1023

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place